AstraZeneca
AZN | NYSE
$186.65
+$12.25 (+7.02%)
At close: Oct 30, 2026, 4:00 PM ET
$185.65
-$1.00 (-0.54%)
Pre-market:
Nov 2, 2026, 7:08 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 15.19B | 15.29B | 15.5B | 15.19B | 14.46B | 13.59B | 14.89B | 13.57B | 12.94B | 12.68B | 12.02B | 11.49B | 11.42B | 10.88B | 11.21B | 10.98B | 10.77B | 11.39B | 12.01B | 9.87B | 8.22B | 7.32B |
Cost of Revenue | 4.02B | 2.68B | 3.12B | 2.8B | 2.47B | 2.24B | 2.73B | 3.08B | 2.18B | 2.22B | 2.31B | 2.1B | 1.96B | 1.91B | 2.9B | 2.98B | 3B | 3.51B | 4.63B | 3.76B | 2.19B | 1.86B |
Gross Profit | 11.18B | 12.61B | 12.39B | 12.39B | 11.98B | 11.35B | 12.17B | 10.48B | 10.76B | 10.46B | 9.72B | 9.4B | 9.46B | 8.97B | 8.31B | 8B | 7.77B | 7.88B | 7.39B | 6.11B | 6.03B | 5.46B |
Operating Income | 3.07B | 4.25B | 2.98B | 3.58B | 3.51B | 3.67B | 2.04B | 2.11B | 2.75B | 3.12B | 1.23B | 1.95B | 2.46B | 2.55B | 1.09B | 1.25B | 539M | 878M | -292M | -1.67B | 1.13B | 1.9B |
Interest Income | 79.01M | 73M | 123M | 85M | 68M | 84M | 64M | 183M | 100M | 111M | 108M | 101M | 64M | 78M | 31M | 15M | 18M | 17M | 1M | 15M | 7M | 20M |
Pretax Income | 2.76B | 3.91B | 2.63B | 3.24B | 3.13B | 3.4B | 1.67B | 1.83B | 2.4B | 2.8B | 897M | 1.65B | 2.09B | 2.26B | 778M | 922M | 247M | 553M | -636M | -2B | 764M | 1.61B |
Net Income | 2.48B | 3.08B | 2.33B | 2.53B | 2.45B | 2.92B | 1.5B | 1.43B | 1.93B | 2.18B | 960M | 1.37B | 1.82B | 1.8B | 901M | 1.64B | 360M | 386M | -347M | -1.65B | 550M | 1.56B |
Selling & General & Admin | 4.49B | 5.06B | 5.65B | 5.23B | 5.01B | 4.63B | 5.55B | 5.29B | 5.06B | 4.63B | 5.52B | 4.93B | 5.12B | 4.19B | 8.31B | 4.4B | 4.81B | 4.97B | 7.53B | 4.21B | 3.2B | 3.03B |
Research & Development | 3.62B | 3.49B | 3.86B | 3.66B | 3.55B | 3.16B | 4.68B | 3.12B | 3.01B | 2.78B | 3.07B | 2.58B | 2.67B | 2.61B | 2.79B | 2.46B | 2.55B | 2.13B | 4.15B | 3.61B | 1.83B | 1.71B |
Other Expenses | -1K | -189M | -100M | -89M | -79M | -113M | -100M | -25M | -60M | -67M | -107M | -70M | -784M | -379M | -3.89B | -106M | -122M | -97M | -3.99B | -37M | -128M | -1.18B |
Operating Expenses | 8.1B | 8.36B | 9.41B | 8.81B | 8.48B | 7.67B | 10.13B | 8.38B | 8.01B | 7.35B | 8.48B | 7.44B | 7B | 6.43B | 7.21B | 6.76B | 7.23B | 7B | 7.68B | 7.78B | 4.9B | 3.56B |
Interest Expense | 429.64M | 393M | 472M | 434M | 439M | 349M | 429M | 457M | 443M | 413M | 445M | 392M | 431M | 365M | 344M | 339M | 311M | 336M | 312M | 335M | 326M | 303M |
Selling & Marketing Expenses | 145M | 141M | 153M | 148M | 143M | 135M | 143M | 145M | 132M | 135M | 145M | 129M | 131M | 134M | 8.31B | 126M | 129M | 125M | 7.53B | 120M | 103M | 99M |
Cost & Expenses | 12.12B | 11.04B | 12.53B | 11.61B | 10.95B | 9.91B | 12.86B | 11.46B | 10.19B | 9.56B | 10.79B | 9.54B | 8.96B | 8.33B | 10.11B | 9.74B | 10.23B | 10.51B | 12.3B | 11.54B | 7.09B | 5.43B |
Income Tax Expense | 287.41M | 833M | 300M | 709M | 679M | 481M | 166M | 395M | 469M | 620M | -62M | 274M | 268M | 458M | -124M | -720M | -113M | 165M | -290M | -350M | 214M | 46M |
Shares Outstanding (Basic) | 775.5M | 774.5M | 775M | 781.79M | 775M | 775M | 775M | 777.02M | 777.02M | 774.5M | 774.5M | 774.5M | 775M | 774.5M | 774.5M | 774M | 774.5M | 774M | 773.5M | 748M | 656M | 656M |
Shares Outstanding (Diluted) | 780M | 780.5M | 781M | 780.5M | 779.5M | 780.5M | 781M | 780M | 780M | 780M | 780.5M | 780M | 780M | 780M | 779.5M | 779.5M | 780M | 780.5M | 773.5M | 748M | 659M | 659.5M |
EPS (Basic) | 3.20 | 3.98 | 3.02 | 3.26 | 3.16 | 3.76 | 1.94 | 1.84 | 1.24 | 2.82 | 1.22 | 1.78 | 2.34 | 2.32 | 1.16 | 2.12 | 0.46 | 0.50 | -0.44 | -2.20 | 0.84 | 2.38 |
EPS (Diluted) | 3.18 | 3.94 | 2.96 | 3.24 | 3.14 | 3.74 | 1.92 | 1.82 | 1.24 | 2.80 | 1.22 | 1.76 | 2.34 | 2.32 | 1.16 | 2.10 | 0.46 | 0.50 | -0.44 | -2.20 | 0.84 | 2.36 |
EBITDA | 4.98B | 5.67B | 4.61B | 5.23B | 4.96B | 5.04B | 2.81B | 4.1B | 4.12B | 4.47B | 2.67B | 3.33B | 3.8B | 4.13B | 2.38B | 2.6B | 1.92B | 2.2B | 1.87B | 1.12B | 1.84B | 2.71B |
EBIT | 3.07B | 4.31B | 3.1B | 3.68B | 3.57B | 3.75B | 2.1B | 2.29B | 2.84B | 3.21B | 1.34B | 2.04B | 2.52B | 2.63B | 1.12B | 1.26B | 558M | 889M | -324M | -1.67B | 1.09B | 1.91B |
Depreciation & Amortization | 1.91B | 1.37B | 1.51B | 1.55B | 1.39B | 1.28B | 714M | 1.82B | 1.28B | 1.26B | 1.33B | 1.28B | 1.28B | 1.5B | 1.25B | 1.33B | 1.36B | 1.31B | 2.19B | 2.79B | 753M | 797M |
Add to Watchlist
Select watchlists to add or remove AZN